Taking all above together, we could propose a model that AQP9 promotes M2-like TAM polarization through Treg-regulated lipid metabolism and P53, JAK/STAT pathways, thereby inhibiting the recruitment of NK and CD8+ T cells, and ultimately stimulates the reorientation of TME in KIRC to a tumor-friendly direction. The gene discussed is AQP9; the disease is neoplasm.